CD274 and neoplasm: However, its efficacy is frequently compromised by immunosuppressive regulation from tumor-associated macrophages (TAMs) within the TIME, which upregulate inhibitory molecules including PD-1, PD-L1, and Tim-3 (Gordon et al., 2017; Dixon et al., 2021).